Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Tasca Logo
Tasca Growth Score
79
CB Rank
27242
Heat Score
64
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Founded
obfuscation
PrivateSeries A Boston, Massachusetts, United States11-50 www.tascatx.com/
Biopharma
Biotechnology
Health Care
Manufacturing
Oncology
Pharmaceutical
Therapeutics
Wellness
Overview

Tasca
Total Funding
obfuscation
Growth Score
79
Heat Score
64

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score79
-1 pts
in past quarter
Heat Score 64
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Tasca

CB Rank
27242
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Founded
obfuscation
PrivateSeries A Boston, Massachusetts, United States11-50 www.tascatx.com/
Biopharma
Biotechnology
Health Care
Manufacturing
Oncology
Pharmaceutical
Therapeutics
Wellness

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name Tasca Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Milenko Cicmil
Phone Number +1 617-390-4306
Contact Email info@tascatx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Small Molecule Drugs for Oncology Indications
Small molecule drugs developed to target hard-to-treat cancer types by inhibiting specific protein lipid-binding pockets.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A
obfuscation
Series A - Tasca Logo
Series A - Tasca
4
obfuscation
Cure Ventures, Regeneron VenturesSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 2 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 10, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

185
-83.6%
 in past month

IT Spend

$43.4KThis year, Tasca is projected to spend $43.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Content Threat Removal Logo
Content Threat Removal
66
Sub-Organizations
Frequently Asked Questions

Where is Tasca's headquarters? Tasca is located in Boston, Massachusetts, United States.Who invested in Tasca? Tasca has 4 investors including Regeneron Ventures and  Invus.When was the last funding round for Tasca? Tasca closed its last funding round on
obfuscation
from a Series A round.Who are Tasca's competitors? Alternatives and possible competitors to Tasca may include Relay Therapeutics, Revolution Medicines, and  Monte Rosa Therapeutics.How much funding has Tasca raised to date? Tasca has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|